ProFoldRX, Inc. — Form D
ProFoldRX, Inc. of AURORA, CO, a company, filed a Form D exempt-offering notice with the SEC on 2013-02-20. The offering totals $1.7M, of which $1.7M was reported sold. Industry: Biotechnology.
Offering
- Filed: 2013-02-20
- Form: D
- Accession: 0001484843-13-000001
- Industry: Biotechnology
- Exemptions: 05, 06
- Total offering: $1.7M
- Amount sold: $1.7M
- Minimum investment: $25K
- Investors: 25
- Date of first sale: 2010-01-15
- Security types: equity
- Revenue range: $1 - $1,000,000
- SEC file number: 021-192147
Issuer
- Name: ProFoldRX, Inc.
- CIK: 0001484843
- Entity type: Corporation
- Jurisdiction: DELAWARE
- Incorporated: 2009
- Address: 12635 MONTVIEW BLVD, AURORA, CO, 80045
- Phone: 303-717-9446
Officers, directors & promoters (7)
| Name | Role | Location |
|---|
| Josh Fidler | Director | Boulder, CO |
| William Freytag | Director | Boulder, CO |
| Kyle Lefkoff | Director | Boulder, CO |
| Kyle Seefeldt | Director | Aurora, CO |
| Kyle Seefeldt | Executive Officer | Aurora, CO |
| Matthew Brewer | Director | Aurora, CO |
| Matthew Brewer | Executive Officer | Aurora, CO |
Other filings by this issuer (2)
More